Johnson & Johnson

JNJ

$174.39

+20.6% (1 year change)

Market Cap

$453 Billion

The market capitalization is the market value of the company. It is the sum of the value of all outstanding shares.

52 Week Range

$131.09 - $173.38

The lowest and highst price in the last 52 weeks.

Price-Earnings Ratio

30.0x

The price-earnings ratio is the ratio between the price per share (stock price) and the earnings per share. It indicates the percentage of the price per share (stock price) that is generated in earnings in the last 12 months.

Dividends per Share

$4.05 (2.35%)

Dividends per share is the amount of dividends paid out to the shareholder of a single share in the last 12 months. The percentage indicates the ratio of the company's annual dividend compared to its current price per share (stock price).

Revenue & Earnings

Balance Sheet

Share Statistics

Market Cap $453 Billion
Enterprise Value $463 Billion
Dividend Yield $4.05 (2.35%)
1 Year Return +22.9%
52-Week High $173.38
52-Week Low $131.09
Beta 0.55
Outstanding Shares 2.63 Billion
Avg 30 Day Volume 6.42 Million

Valuation

P/E Ratio 30.0
PEG 433.59
Earnings per Share $5.66
Price to Sales Ratio 5.63
Price to Book Ratio 7.27
Revenue to Enterprise Value 5.5
EBIT to Enterprise Value 22.37
Total Debt to Enterprise Value 0.08
Debt to Equity 0.56

Profitability

Revenue $84.2 Billion
Gross Profit $55.8 Billion
EBIT $20.7 Billion
Net Income $15.1 Billion
Profit Margin 17.95%
Quarterly Earnings Growth (YoY) +6.9%
Return on Equity 23.89%
Return on Assets 8.64%
Return on Invested Capital 15.65%

Johnson & Johnson

At Johnson & Johnson, we believe good health is the foundation of vibrant lives, thriving communities and forward progress. That’s why for more than 130 years, we have aimed to keep people well at every age and every stage of life. Today, as the world’s largest and most broadly-based healthcare company, we are committed to using our reach and size for good. We strive to improve access and affordability, create healthier communities, and put a healthy mind, body and environment within reach of everyone, everywhere. We are blending our heart, science and ingenuity to profoundly change the trajectory of health for humanity.

News

600 walk-in vaccination doses available at Themba CDC

600 walk-in vaccination doses available at Themba CDC

GEORGE NEWS - The Thembalethu Community Day Centre (CDC) is able to vaccinate 600 walk-in clients of 35 years and older from Wednesday till Friday, 4 to 6 August. This is for the Johnson Johnson

GeorgeHerald GeorgeHerald, about 14 hours ago
UK, Germany Join Israel In Offering Booster Jabs To Most Vulnerable

UK, Germany Join Israel In Offering Booster Jabs To Most Vulnerable

UK, Germany Join Israel In Offering Booster Jabs To Most Vulnerable As Israel starts doling out the first booster shots (courtesy of Pfizer, which has just shipped millions of additional jabs to th...

Zero Hedge Zero Hedge, 1 day ago
Johnson & Johnson withdraws proposal seeking accelerated covid vaccine approval in India

Johnson & Johnson withdraws proposal seeking accelerated covid vaccine approval in India

The firm has informed that they are withdrawing their proposal, India''s drug regulator said.

Livemint Livemint, 3 days ago